Last updated on: 4/2/2009 | Author:

Anita I. Holdcroft, MD Biography

Clinical Reader at the Division of Surgery, Oncology, Reproductive Biology, and Anaesthetics at Imperial College, London
Not Clearly Pro or Con to the question "Should Marijuana Be a Medical Option?"

“In this dose-escalation study of a single dose of 5, 10, or 15 mg cannabis extract, the two higher doses… decreased pain intensity at rest…

These values are similar to… commonly used orally administered drugs for moderate pain intensity such as morphine, paracetamol, and ibuprofen and indicate a potential role for cannabinoids in postoperative pain management.”

“A Multicenter Dose-escalation Study of the Analgesic and Adverse Effects of an Oral Cannabis Extract (Cannador) for Postoperative Pain Management,” Journal of Anesthesiology, May 2006

Theoretical Expertise Ranking:
     Key Experts
Physicians [Physicians are the "key experts" in the medical marijuana debate because the issue is thought by many to be ultimately based on the medical value and risks of marijuana, and Physicians, with their training and clinical work, should (at least in theory) have the best knowledge of marijuana's medical value and risks.] [Note: Key Experts definition varies by sites that have this designation.]
Involvement and Affiliations:
  • Clinical Reader, Division Surgery, Oncology, Reproductive Biology, and Anaesthetics, Imperial College (London, UK)
  • Honorary Consultant Anaesthetist, Chelsea & Westminster Hospital, London, UK
  • President, Forum on Maternity and the Newborn at the Royal Society of Medicine, London
  • Secretary and Co-chair, Special Interest Group on Sex Gender and Pain of the International Association for the Study of Pain, 1999-2005
  • National Anaesthetic Advisor, Confidential Enquiry into Maternal and Child Health Diabetes Project
  • Elected Representative, British Medical Association (BMA) Council
  • Editorial Board Member, International Journal of Obstetric Anaesthesia
  • MD, School unknown
  • None found